Logo
I

ImmuneBridge

15 employees

ImmuneBridge is developing allogeneic immunotherapies for cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Information Technology
CAR-NK
Immunotherapy
Cell Therapy
Health Care
Oncology
Natural Killer Cells

Date founded

2018

Funding rounds raised

Total raised

$12M

from 4 investors over 4 rounds

I

ImmuneBridge raised $12M on January 9, 2023

Investors: One Way Ventures, M Ventures and Insight Partners

I

ImmuneBridge raised undisclosed on May 8, 2018

Investors: Quiet Capital

FAQ